申请人:——
公开号:US20020061868A1
公开(公告)日:2002-05-23
The invention concerns pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives as active ingredients which carry a group of the general formula
R—SO
2
—O—
at their C3 position wherein
R is a R
1
R
2
N group wherein
R
1
and R
2
are independent of each other and represent a hydrogen atom, a C
1
-C
5
alkyl radical or, together with the N atom, a polymethylene imino radical containing 4 to 6 C atoms, or a morpholino radical.
The preparations according to the invention can be used for hormonal contraception and for hormon replacement therapy (HRT). They exhibit a low hepatic estrogenity.
该发明涉及含有以Estra-1,3,5(10)-三烯衍生物为活性成分的制药制剂,其在其C3位置携带一个通式R—SO2—O—的基团,其中R是一个R1R2N基团,其中R1和R2彼此独立,并表示氢原子,C1-C5烷基基团,或者与N原子一起,含有4到6个碳原子的聚甲烯基亚胺基团,或者是吗啡啉基团。根据该发明的制剂可用于激素避孕和激素替代疗法(HRT)。它们表现出低肝雌激素性。